Next-generation negative symptom assessment for clinical trials: validation of the Brief Negative Symptom Scale. - sprookjes - yvandenbroek - TriplyDB

Next-generation negative symptom assessment for clinical trials: validation of the Brief Negative Symptom Scale.

Next-generation negative symptom assessment for clinical trials: validation of the Brief Negative Symptom Scale.

http://www.wikidata.org/entity/Q36412864

about

Addressing the unmet needs of patients with persistent negative symptoms of schizophrenia: emerging pharmacological treatment options Motivational Deficits in Schizophrenia and the Representation of Expected Value Automated computerized analysis of speech in psychiatric disorders.Emotion regulation abnormalities in schizophrenia: cognitive change strategies fail to decrease the neural response to unpleasant stimuli The motivation and pleasure dimension of negative symptoms: neural substrates and behavioral outputs.Effort, anhedonia, and function in schizophrenia: reduced effort allocation predicts amotivation and functional impairment Brain structural signatures of negative symptoms in depression and schizophrenia The role of low cognitive effort and negative symptoms in neuropsychological impairment in schizophrenia Plasma oxytocin levels predict social cue recognition in individuals with schizophrenia.Endogenous oxytocin levels are associated with the perception of emotion in dynamic body expressions in schizophrenia.Do negative symptoms of schizophrenia change over time? A meta-analysis of longitudinal data.Emotion regulation abnormalities in schizophrenia: Directed attention strategies fail to decrease the neurophysiological response to unpleasant stimuli Instruments measuring blunted affect in schizophrenia: a systematic review Medial frontal GABA is lower in older schizophrenia: a MEGA-PRESS with macromolecule suppression study The brief negative symptom scale: validation of the German translation and convergent validity with self-rated anhedonia and observer-rated apathy.Factor structure of the Brief Negative Symptom Scale.Avolition in schizophrenia is associated with reduced willingness to expend effort for reward on a Progressive Ratio task.Self-Evaluation of Negative Symptoms: A Novel Tool to Assess Negative Symptoms.A Two-Factor Model Better Explains Heterogeneity in Negative Symptoms: Evidence from the Positive and Negative Syndrome Scale Effectiveness of fast mapping to promote learning in schizophrenia.Motivational and Behavioral Activation as an Adjunct to Psychiatric Rehabilitation for Mild to Moderate Negative Symptoms in Individuals with Schizophrenia: A Proof-of-Concept Pilot Study.Assessment of trait and state aspects of depression in schizophrenia.Frontal-striatum dysfunction during reward processing: Relationships to amotivation in schizophrenia Progress in the study of negative symptoms.Elevated brain lactate in schizophrenia: a 7 T magnetic resonance spectroscopy study.Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia.Psychometric evaluation of the negative syndrome of schizophrenia.Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward.Initial development and preliminary psychometric properties of the Prodromal Inventory of Negative Symptoms (PINS).The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia.SoCIAL - training cognition in schizophrenia: a pilot study.Validation of the Korean Version of the Clinical Assessment Interview for Negative Symptoms.A Psychometric Comparison of the Clinical Assessment Interview for Negative Symptoms and the Brief Negative Symptom Scale.New Standards for Negative Symptom Assessment.Paradigms for Assessing Hedonic Processing and Motivation in Humans: Relevance to Understanding Negative Symptoms in Psychopathology.Social cognition in people with schizophrenia: a cluster-analytic approach.A Transdiagnostic Review of Negative Symptom Phenomenology and Etiology.Validation of Turkish version of brief negative symptom scale.Ecological momentary assessment of negative symptoms in schizophrenia: Relationships to effort-based decision making and reinforcement learning.Negative Symptom Dimensions of the Positive and Negative Syndrome Scale Across Geographical Regions: Implications for Social, Linguistic, and Cultural Consistency.

P2860

Q22241447-D11EE0BC-384C-4956-A0CB-318DDF262BB1 Q26786992-4A6A2F2A-DF98-441C-B20F-6D6E0834B571 Q30412969-54AAEBCA-F533-49DE-A734-433EC2C76844 Q30540763-6B390307-506E-4280-8696-0145AF94097A Q33610776-D4C9523F-C22D-47AE-9BB0-9730BFB017B4 Q33724110-A1A6EE24-866A-41F8-8404-F6C29D979461 Q34093633-20362951-5DBD-4664-AC62-3E673D697E29 Q34861684-1CA633ED-5850-4074-B042-8F54E2CE8B84 Q35116515-06978B21-EAB3-4A56-9FE7-262E2544474A Q35118062-1FC9D2FE-6878-460D-A978-68FB6876AA24 Q35450483-BA5B84DA-5427-4988-9AA3-5B6CC9CC66B5 Q35598024-7FF07A66-6288-4E7A-8532-8D8C7BF1AE13 Q35649715-962C518F-9379-4ED1-AA4E-D3A8CFACB1CC Q36113065-8B4E106C-F622-4920-9D37-16F37A14280B Q36201440-0C3893AD-ABDE-4EB5-9445-C40A8FA23A8E Q36412889-0D83276E-B0B0-4751-8EAD-D5E824D7FA74 Q36447607-E4D24C64-0E3F-406A-90C2-234B0E867E5C Q36817178-7C4CFCAF-6C93-4448-A3A1-DFE345DE76CC Q36892223-E7C4560C-F1E7-498A-9E40-1E36A5F36598 Q37354038-F8353C49-9221-462A-B63F-E4B292A8A827 Q37411272-551D4447-F48A-42FB-BD3C-62D5DA55AD81 Q37451474-E9D9140B-6C44-4829-80F7-A5EC0E383D8B Q37463028-B6973CF4-FD5D-4CD0-912D-9D0BB456CC75 Q37602615-B2D65E05-3AB7-459C-95F9-A5CEA408DA05 Q37622674-5CB7D428-EF91-4830-8E32-1FCD8915048E Q38268878-4954255B-A3D5-40C5-975C-4CB60518E7CD Q38388526-82BDD338-6B48-45BB-AF6C-5A4505ED9EF2 Q38683538-D7DC1EED-32A6-42A2-9EC6-9C86F0A95C54 Q38758518-2B853640-4C16-47AE-8D1C-53FF2C7CE6C2 Q39269381-C734BE5F-3E9B-434D-8383-0B70794409CC Q41144296-8E4698E0-6CA2-451D-BB0E-F333EDDC297D Q41449680-EEF78313-E439-43B1-9E59-A9879DD62DA1 Q42650165-2C281D22-D549-489E-8DDB-EB47EDC16726 Q43126077-BA08C793-A7D8-41C1-8F59-1E24FA330BED Q46689450-7E295FCE-2918-4272-A6B8-AFB5F591213A Q47656378-AA95BBB3-237F-4249-9F64-C02AC9C1A14A Q47919387-374005F2-87DE-4ECB-9C60-EAC8F997391B Q48049011-00895A1B-B110-4AB6-9EFF-AE4D43F78912 Q48414834-64DA7F4A-175F-4797-BE6C-BADBE5ABE1F7 Q48499627-A95AE038-FD9D-4148-AFD4-D193BF0CDDA4

P2860

Next-generation negative symptom assessment for clinical trials: validation of the Brief Negative Symptom Scale.

http://www.wikidata.org/entity/Q36412864

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Next-generation negative sympt ...... Brief Negative Symptom Scale.

@ast

Next-generation negative sympt ...... Brief Negative Symptom Scale.

@en

type

label

Next-generation negative sympt ...... Brief Negative Symptom Scale.

@ast

Next-generation negative sympt ...... Brief Negative Symptom Scale.

@en

prefLabel

Next-generation negative sympt ...... Brief Negative Symptom Scale.

@ast

Next-generation negative sympt ...... Brief Negative Symptom Scale.

@en

P1433

Q36412864-30B425D7-72E8-4CA9-9D1B-D85987D5D87A

P1476

Q36412864-1DC6F472-EB64-49AE-B9DE-52C9AFBB2D52

P2093

Q36412864-05162A76-6EA1-42AB-9896-ACF7E01CD949

Q36412864-383CBCE0-71F9-4C3C-98F1-0BA8F42C65FA

Q36412864-410FE152-8A54-4D62-8B8B-7ECCCCEA2BC8

Q36412864-4AF547DB-B1BF-4565-B0A4-D1D5FD6CE61C

Q36412864-553F2546-78C4-4616-8CBF-F1C333DA2666

Q36412864-91AA53F7-69E3-47C3-8538-8293E6D248A1

Q36412864-AADE990E-6B44-46BD-9609-D9BC03A38E8F

Q36412864-E2BF90AA-2283-45CB-AF70-217C3A8569CD

Q36412864-FD2F0F2B-356B-4CE8-8BA4-05B547011BA2

P2860

Q36412864-105993CC-3594-403B-8C97-22EAB19A8648

Q36412864-1E362BCC-074E-4572-84FC-E719935B884C

Q36412864-28056E4B-A11D-473C-84BC-41CA2E5FF2D4

Q36412864-2CDC87FA-7E64-423B-B455-35D457DF0708

Q36412864-443D985F-B6B4-4F58-A66B-1002B1459889

Q36412864-64659D14-3996-4E0A-82E3-29F08EC77230

Q36412864-6B2AE2F0-7775-4D85-A12E-AD0C874BAB84

Q36412864-784F64E8-1B75-4A3D-B867-ABEED398E345

Q36412864-7943D3DF-ED2F-4FF7-B436-767519E74FD8

Q36412864-826DB9FC-F1D1-4F95-AC61-4EA1BA7D82F9

P304

Q36412864-9FFBA4C4-D13E-4848-A6DD-82A4CC10ECB9

P31

Q36412864-DC1D44FF-64C6-4BE1-B8E6-7D563F08B1BE

P356

Q36412864-4E5758B8-73BA-47D6-91C4-DD8DD9EB8F28

P407

Q36412864-8EEC0D45-5B41-4A36-A4A6-5A6A37C77D1B

P433

Q36412864-69C96967-6FEB-412F-9D34-A06F43C1548D

P478

Q36412864-D98398CD-D797-4C24-B9E9-A82F57E9944E

P50

Q36412864-e93c56aa-41a5-df24-e8d7-214a3c98f68e

P577

Q36412864-F47230ED-D656-4E48-80B6-1E8E0EFCC1AF

P5875

Q36412864-B8B7D5DC-01C7-45C0-A722-D76AFAAC29D7

P698

Q36412864-7343FD59-7459-4409-B650-8F1DD5742BC8

P932

Q36412864-7BACC93F-6AB7-4A37-A106-12011EF59371

P356

J.SCHRES.2012.10.012

P1433

Schizophrenia Research

P1476

Next-generation negative sympt ...... Brief Negative Symptom Scale.

@en

P2093

Adam J Culbreth

http://www.w3.org/2001/XMLSchema#string

Bernard A Fischer

http://www.w3.org/2001/XMLSchema#string

Gregory P Strauss

http://www.w3.org/2001/XMLSchema#string

James M Gold

http://www.w3.org/2001/XMLSchema#string

Lauren T Catalano

http://www.w3.org/2001/XMLSchema#string

Robert P McMahon

http://www.w3.org/2001/XMLSchema#string

Robert W Buchanan

http://www.w3.org/2001/XMLSchema#string

William R Keller

http://www.w3.org/2001/XMLSchema#string

William T Carpenter

http://www.w3.org/2001/XMLSchema#string

P2860

Negative symptoms and cognitive deficits: what is the nature of their relationship?

The brief negative symptom scale: psychometric properties.

Domains of psychopathology: an approach to the reduction of heterogeneity in schizophrenia.

Periods of recovery in deficit syndrome schizophrenia: a 20-year multi-follow-up longitudinal study.

A separate disease within the syndrome of schizophrenia.

Negative symptoms in schizophrenia. Definition and reliability.

Initial development and preliminary validation of a new negative symptom measure: the Clinical Assessment Interview for Negative Symptoms (CAINS).

Deficits in positive reinforcement learning and uncertainty-driven exploration are associated with distinct aspects of negative symptoms in schizophrenia.

Toward the next generation of negative symptom assessments: the collaboration to advance negative symptom assessment in schizophrenia.

Anhedonia in schizophrenia: distinctions between anticipatory and consummatory pleasure

P304

88-92

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.SCHRES.2012.10.012

http://www.w3.org/2001/XMLSchema#string

P407

P433

1-3

http://www.w3.org/2001/XMLSchema#string

P478

142

http://www.w3.org/2001/XMLSchema#string

P50

Brian Kirkpatrick

P577

2012-11-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232930224

http://www.w3.org/2001/XMLSchema#string

P698

23127378

http://www.w3.org/2001/XMLSchema#string

P932

3502630

http://www.w3.org/2001/XMLSchema#string